Next |
home / stock / kmda / kmda message board
Subject | By | Source | When |
---|---|---|---|
Kamada Issues 2023 CEO Letter to Shareholders | midastouch017 | investorshub | 03/15/2023 1:27:04 PM |
Kamada Reports Strong Fiscal Year and Fourth Quarter | midastouch017 | investorshub | 03/15/2023 1:25:36 PM |
Kamada Announces Submission of Application to the U.S. | midastouch017 | investorshub | 01/04/2023 1:30:07 PM |
Kamada Provides Update on Recent Progress Achieved in | midastouch017 | investorshub | 11/07/2022 12:40:17 PM |
Kamada Awarded $22 Million Extension of Canadian Supply Tender | midastouch017 | investorshub | 10/19/2022 12:21:17 PM |
Kamada Reports Second Quarter and First Half 2022 | midastouch017 | investorshub | 08/17/2022 12:40:34 PM |
Kamada Announces $11.4 Million International VARIZIG® Procurement Agreement | midastouch017 | investorshub | 07/06/2022 12:18:11 PM |
Kamada ($KMDA) Gets a Buy Rating from H.C. Wainwright | midastouch017 | investorshub | 03/16/2022 1:12:44 PM |
Kamada Ltd.'s ($KMDA) CEO Amir London On Q4 | midastouch017 | investorshub | 03/15/2022 5:24:31 PM |
Kamada Reports Fiscal Year and Fourth Quarter 2021 | midastouch017 | investorshub | 03/15/2022 1:24:22 PM |
Kamada Issues 2022 CEO Letter to Shareholders | midastouch017 | investorshub | 03/15/2022 1:04:30 PM |
FDA updates EUA for COVID convalescent plasma limiting | midastouch017 | investorshub | 12/29/2021 5:17:30 AM |
Kamada Ltd. (KMDA) CEO Amir London on Q3 | midastouch017 | investorshub | 11/22/2021 5:31:41 PM |
Kamada Reports Third Quarter and First Nine Months | midastouch017 | investorshub | 11/22/2021 1:35:55 PM |
Kamada Announces Strategic Transformational Transaction Positioning the Compa | midastouch017 | investorshub | 11/22/2021 1:22:07 PM |
Kamada Limited ($KMDA) CEO Amir London on Q2 | midastouch017 | investorshub | 08/12/2021 5:28:12 AM |
Kamada Reports Second Quarter and First Half 2021 | midastouch017 | investorshub | 08/11/2021 11:55:09 AM |
Kamada to Announce Second Quarter and First Half | midastouch017 | investorshub | 08/05/2021 12:18:33 PM |
6.30+0.48 (+8.25%) | midastouch017 | investorshub | 06/25/2021 5:31:14 PM |
Hedge Funds Are Selling Kamada Ltd ($KMDA) | midastouch017 | investorshub | 06/18/2021 4:32:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Kamada Ltd. Company Name:
KMDA Stock Symbol:
NASDAQ Market:
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Revenues for First Quarter of 2024 were $37.7 Million, Representing a 23% Increase Year-over-Year First Quarter 2024 Adjusted EBITDA of $7.5 Million, Representing a 96% Increase Year-over-Year Momentum Primarily Driven by U.S. Sales of the Company’s Two Most Significant Cat...
REHOVOT, Israel and HOBOKEN, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, to...